Zinc, vitamin C show no benefit in randomized trial


By Reuters Staff

(Reuters) - In adult outpatients with COVID-19, high doses of zinc or vitamin C, or both, failed to improve their symptoms or speed their recovery, researchers reported in JAMA Network Open.

They randomly assigned 214 patients to 10 days of treatment with either a high dose of zinc, vitamin C, both, or neither, plus standard care.

There was no significant difference between the groups in the number of days required to reach a 50% reduction in symptoms like fever, cough, shortness of breath, and fatigue -- the primary outcome.

There was also no difference in the number of days until patients no longer had severe symptoms, in need for other prescribed medications, or in rates of hospitalizations and deaths.

Zinc and vitamin C (ascorbic acid) supplements "cannot be recommended" to ease the course of COVID-19 in outpatients, the researchers concluded.

"Most consumers of ascorbic acid and zinc are taking significantly lower doses of these supplements, so demonstrating that even high-dose ascorbic acid and zinc had no benefit suggests clear lack of efficacy," they said.

SOURCE: https://bit.ly/3ppTy5f JAMA Network Open, online February 12, 2021.

Related Articles

Pregnant women infected by COVID-19 at higher rate

By Reuters Staff (Reuters) - Pregnant women become infected with the new coronavirus at higher rates than other adults, according to new data from Washington state. Between March and June there, for Read More »

UPDATE 1-COVID-19 vaccine makers tell Congress U.S. supply will surge soon

(Adds new details from hearing, CVS, background) By Michael Erman and Manojna Maddipatla NEW YORK (Reuters) - COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the Read More »

French COVID-19 intensive care patients at a 12-week high

By Reuters Staff PARIS (Reuters) - France's number of patients treated in intensive care units for COVID-19 has gone up again on Tuesday, reaching a 12-week peak of 3,435 as regional officials urge Read More »

© 2021 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use
Do Not Sell My Personal Information